98 related articles for article (PubMed ID: 8834838)
1. [Antiarrhythmic effects of prajmaline (Neo-Gilurythmal) in stable angina pectoris in light of Holter electrocardiographic monitoring].
Janicki K; Orski J; Kakol J
Przegl Lek; 1995; 52(10):485-491. PubMed ID: 8834838
[TBL] [Abstract][Full Text] [Related]
2. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
[TBL] [Abstract][Full Text] [Related]
3. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
[TBL] [Abstract][Full Text] [Related]
4. [Use of transesophageal left atrial cardiac pacing for assessment of cordarone effectiveness in patients with atrioventricular tachycardia].
Matiushin GV; Shul'man VA; Balog AI; Golovenkin SE; Bezruk AP; Ivanitskiĭ EA; Smirnova OV
Ter Arkh; 1998; 70(6):47-50. PubMed ID: 9695227
[TBL] [Abstract][Full Text] [Related]
5. [Magnesium or proajmaline (neogilurytmal) in treatment of recurrences of paroxysmal supraventricular tachyarrhythmias?].
Dłuzniewski M; Król J
Wiad Lek; 1994 Oct; 47(19-20):721-4. PubMed ID: 7483616
[TBL] [Abstract][Full Text] [Related]
6. Flecainide acetate: concentration-response relationships for antiarrhythmic and electrocardiographic effects.
Boriani G; Capucci A; Strocchi E; Calliva R; Santarelli A; Biffi M; Magnani B
Int J Clin Pharmacol Res; 1993; 13(4):211-9. PubMed ID: 8150547
[TBL] [Abstract][Full Text] [Related]
7. Flecainide as first-line treatment for supraventricular tachycardia in newborns.
Ferlini M; Colli AM; Bonanomi C; Salvini L; Galli MA; Salice P; Ravaglia R; Centola M; Danzi GB
J Cardiovasc Med (Hagerstown); 2009 May; 10(5):372-5. PubMed ID: 19300276
[TBL] [Abstract][Full Text] [Related]
8. [Effect of flecainide on chronic ventricular arrhythmias (author's transl)].
Bluschke V; Breithardt G; Abendroth RR; Seipel L
Z Kardiol; 1982 Apr; 71(4):284-8. PubMed ID: 6178228
[TBL] [Abstract][Full Text] [Related]
9. [Role of ambulatory ECG in a cardiology department].
Pesola A; Magini G
G Ital Cardiol; 1987 Dec; 17(12):1055-62. PubMed ID: 3503801
[TBL] [Abstract][Full Text] [Related]
10. Comparison of tocainide and prajmalium bitartrate for the treatment of ventricular arrhythmias.
Schwartzkopff B; Schilling G; Simon H
Arzneimittelforschung; 1983; 33(1):153-8. PubMed ID: 6403021
[TBL] [Abstract][Full Text] [Related]
11. [Prajmalium bitartrate in hyperkinetic ventricular arrhythmias in infarct patients during rehabilitation].
Molinis G; Valente M; Tuniz D; Maisano G
G Ital Cardiol; 1981; 11(6):749-57. PubMed ID: 7319182
[TBL] [Abstract][Full Text] [Related]
12. Individual patterns of dynamic QT/RR relationship in survivors of acute myocardial infarction and their relationship to antiarrhythmic efficacy of amiodarone.
Smetana P; Pueyo E; Hnatkova K; Batchvarov V; Laguna P; Malik M
J Cardiovasc Electrophysiol; 2004 Oct; 15(10):1147-54. PubMed ID: 15485438
[TBL] [Abstract][Full Text] [Related]
13. Assessment of nonlinear heart rate dynamics after beating-heart revascularization.
Ksela J; Suwalski P; Kalisnik JM; Avbelj V; Suwalski G; Gersak B
Heart Surg Forum; 2009 Jan; 12(1):E10-6. PubMed ID: 19233759
[TBL] [Abstract][Full Text] [Related]
14. Dobutamine effects on spontaneous variability of ventricular arrhythmias in patients with severe chronic heart failure: the Italian Multicenter Study.
Puddu PE; Papalia U; Schiariti M; Usta C;
Ital Heart J; 2004 Sep; 5(9):693-701. PubMed ID: 15568599
[TBL] [Abstract][Full Text] [Related]
15. Trimetazidine added to combined hemodynamic antianginal therapy in patients with type 2 diabetes: a randomized crossover trial.
Ribeiro LW; Ribeiro JP; Stein R; Leitão C; Polanczyk CA
Am Heart J; 2007 Jul; 154(1):78.e1-7. PubMed ID: 17584555
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of the neo-gilurhythmal use in therapy of the heart rhythm disorders (author's transl)].
Trojanowicz R
Przegl Lek; 1979; 36(8):627-9. PubMed ID: 92042
[No Abstract] [Full Text] [Related]
17. Predictors of arrhythmic events during second day monitoring in patients with normal first day Holter recordings.
Arya A; Haghjoo M; Khosrawi A; Emkanjoo Z; Sadr-Ameli MA
Indian Heart J; 2005; 57(3):241-4. PubMed ID: 16196182
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of prajmaline (Neo-Gilurytmal) objectifiable by means of a test].
Fortschr Med; 1983 May; 101(17):809-10. PubMed ID: 6190722
[No Abstract] [Full Text] [Related]
19. How to evaluate class III antiarrhythmic drug efficacy clinically: the benefits and shortcomings of the noninvasive approach.
Andresen D; Behrens S; Stern R; Brüggemann T; Schröder R
J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S28-31. PubMed ID: 1279306
[TBL] [Abstract][Full Text] [Related]
20. Effect of levosimendan on ventricular arrhythmias and prognostic autonomic indexes in patients with decompensated advanced heart failure secondary to ischemic or dilated cardiomyopathy.
Flevari P; Parissis JT; Leftheriotis D; Panou F; Kourea K; Kremastinos DT
Am J Cardiol; 2006 Dec; 98(12):1641-5. PubMed ID: 17145226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
